DuPont Nutrition & Health has received approval from the Brazilian Health Regulatory Agency (ANVISA) recognizing a health claim for the Bifidobacterium lactis HN019™ probiotic strain.
Customers in Brazil can now bring new probiotic foods and dietary supplements faster to market using the first DuPont probiotic to qualify for an
DuPont Nutrition & Health has received approval from the Brazilian Health Regulatory Agency (ANVISA) recognizing a health claim for the Bifidobacterium lactis HN019™ probiotic strain.
Customers in Brazil can now bring new probiotic foods and dietary supplements faster to market using the first DuPont probiotic to qualify for an approved health claim in the local market.
The approved health claim is an important win for DuPont and a powerful recognition of the science behind the Bifidobacterium lactis HN019™ probiotic strain.
The approval means foods and supplements containing the strain can now include the claim ‘Bifidobacterium lactis HN019™ may contribute to gastrointestinal health’ on product packaging.
approved health claim in the local market.
The approved health claim is an important win for DuPont and a powerful recognition of the science behind the Bifidobacterium lactis HN019™ probiotic strain.
The approval means foods and supplements containing the strain can now include the claim ‘Bifidobacterium lactis HN019™ may contribute to gastrointestinal health’ on product packaging.